EU turns to BioNTech/Pfizer after J&J vaccine suspension

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

Diseases, Conditions, Syndromes

Central line-associated bloodstream infections increased in 2020

(HealthDay)—The national standardized infection ratio (SIR) for central line-associated bloodstream infections (CLABSIs) increased significantly in the second quarter (Q2) of 2020 compared with Q2 in 2019, with COVID-19 ...


EU chief says AstraZeneca shortfalls slow vaccine campaign

The European Union's chief executive criticized Anglo-Swedish vaccine-maker AstraZeneca on Wednesday, accusing the embattled pharmaceutical company of delaying Europe's coronavirus vaccination campaign and warning that the ...

page 1 from 5